Pyxis Oncology, Inc. PYXS
2.86
(0.06)
(2.05%)
as of 25 Sep
- Market cap
- $250.2M
- P/E
- 0.0×
Follow PYXS
| Dec '17 | Dec '19 | Dec '20 | Dec '21 | Dec '22 | Dec '23 | Dec '24 | Dec '25 | |
|---|---|---|---|---|---|---|---|---|
P/E ratio |
— | — | — | — | — | — | 0.00 | 0.00 |
P/S ratio |
— | — | — | — | — | — | 0.00 | 0.00 |
P/FCF ratio |
— | — | — | — | — | — | 0.00 | 0.00 |
P/Operating CF |
— | — | — | — | — | — | (4.73) | (6.85) |
P/B ratio |
— | — | — | — | — | — | 0.76 | 1.34 |
Price to Tangible BV |
— | — | — | — | — | — | 0.77 | 1.40 |
EV/Sales |
— | — | — | — | — | — | 0.00 | 0.00 |
EV/EBITDA |
— | — | — | — | — | — | 0.40 | 0.00 |
EV/Operating CF |
— | — | — | — | — | — | 0.65 | (0.05) |
EV/FCF |
— | — | — | — | — | — | 0.64 | (0.05) |
Quick Ratio |
— | 26.86 | 2.19 | 14.76 | 5.71 | 4.69 | 7.26 | 3.23 |
Current Ratio |
— | 26.88 | 2.20 | 14.90 | 5.90 | 4.84 | 7.49 | 3.41 |
Net Debt/EBITDA |
— | 6.83 | 0.65 | 4.00 | 1.47 | 1.42 | 1.39 | 0.82 |
Debt/Assets |
0.00% | 0.08% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
Debt/Equity |
— | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Asset Turnover |
— | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.10 | 0.11 |
Operating CF/Net income |
— | 0.81 | 0.79 | 0.47 | 0.74 | 0.96 | 0.75 | 0.80 |
Capex/Depreciation |
— | — | (3.16) | (0.83) | (9.03) | 2.35 | 0.08 | (0.01) |
Interest Coverage |
— | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| — | 29.94% | 138.54% | (61.85%) | (57.19%) | (51.51%) | (62.75%) | (91.43%) | |
| — | (27.99%) | (85.64%) | (52.37%) | (49.13%) | (38.32%) | (46.74%) | (64.03%) | |
ROIC |
— | 0.00% | 0.00% | 0.00% | 0.00% | (1,041.19%) | 0.00% | 0.00% |
Return on Tangible Assets |
— | (14.56%) | (232.52%) | (29.11%) | (72.66%) | (66.65%) | (62.03%) | (135.02%) |
Average Days of Receivables |
— | — | — | — | 0.00 | — | 0.00 | 0.00 |
Research and Development Expense of Revenue |
— | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 363.85% | 531.79% |
Selling, General and Administrative Expense of Revenue |
— | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 157.44% | 160.15% |
Intangible Assets out of Total Assets |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.14 | 0.02 | 0.00 |
Share Based Compensation of Revenue |
— | — | 0.00% | 0.00% | 0.00% | 0.00% | 80.17% | 85.16% |
Graham Net Nets |
— | — | — | — | — | — | 1.05 | 0.48 |
Graham Number |
— | — | — | — | — | — | 0.00 | 0.00 |
Earnings Yield |
— | — | — | — | — | — | (83.33%) | (112.17%) |
Free Cash Flow Yield |
— | — | — | — | — | — | (63.51%) | (88.87%) |
Revenue per Share |
— | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.28 | 0.22 |
Operating CF per Share |
— | (0.07) | (9.78) | (4.16) | (2.70) | (1.77) | (0.99) | (1.02) |
Capex per Share |
— | 0.00 | (1.44) | (0.06) | (0.19) | (0.17) | 0.00 | 0.00 |
Free Cash Flow per Share |
— | (0.07) | (11.22) | (4.22) | (2.90) | (1.94) | (0.99) | (1.02) |
Cash per Share |
— | 0.57 | 7.84 | 32.52 | 5.47 | 3.03 | 2.20 | 1.10 |
Shareholders Equity per Share |
— | 0.56 | (15.17) | 30.77 | 4.87 | 3.15 | 2.07 | 0.86 |
Interest Debt per Share |
— | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Book value per Share |
— | 0.56 | (15.17) | 30.77 | 4.87 | 3.15 | 2.07 | 0.86 |
Free Cash Flow |
— | (2.24) | (11.57) | (35.87) | (95.73) | (77.43) | (57.91) | (63.51) |
Working Capital |
— | 18.97 | 4.41 | 259.97 | 154.98 | 98.85 | 114.76 | 50.97 |
Capital Expenditures |
— | — | (1.48) | (0.54) | (6.40) | (6.73) | (0.24) | (0.01) |
Net Current Asset Value |
— | 18.96 | (17.69) | 259.97 | 136.06 | 76.58 | 96.01 | 33.99 |
EV/EBIT |
— | — | — | — | — | — | 0.42 | 0.00 |
Capex to Sales |
— | — | 0.00 | 0.00 | 0.00 | 0.00 | 0.01 | 0.00 |
Net Profit Margin |
— | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | (478.95%) | (574.55%) |
Price to Operating Income |
— | — | — | — | — | — | 0.00 | 0.00 |
| Other line items | ||||||||
Depreciation/Fixed assets |
— | 0.00 | 0.43 | 0.64 | 0.06 | (0.24) | (0.32) | 0.19 |
Cash ROIC |
— | (5.97%) | 147.88% | (6.76%) | (29.42%) | (33.50%) | (27.12%) | (58.73%) |
Accounts Receivable Turnover |
— | — | — | — | — | — | 0.00 | 0.00 |
Accounts Payable Turnover |
— | 0.00 | 0.57 | 0.19 | 0.19 | 0.00 | 0.11 | 0.30 |
Inventory Turnover |
— | — | 0.00 | 0.00 | 0.00 | — | 0.00 | 0.00 |
Average Days of Payables |
— | 0.00 | 885.37 | 3,486.90 | 1,410.90 | 0.00 | 3,733.76 | 1,663.75 |
Days of Inventory on Hand |
— | — | 0.00 | 0.00 | 0.00 | — | 0.00 | 0.00 |
Average Payables |
— | 0.78 | 0.78 | 6.51 | 9.52 | 5.50 | 4.38 | 7.87 |
Average Assets |
— | 9.90 | 14.98 | 145.09 | 245.70 | 192.55 | 165.45 | 124.35 |
Average Common Equity |
— | (9.26) | (9.26) | 122.83 | 211.07 | 143.26 | 123.23 | 87.08 |
Columns are period end dates